These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Controversies in cardiovascular medicine. Benefits of surgery in obstructive hypertrophic cardiomyopathy: bring septal myectomy back for European patients. Maron BJ; Yacoub M; Dearani JA Eur Heart J; 2011 May; 32(9):1055-8. PubMed ID: 21324934 [TBL] [Abstract][Full Text] [Related]
9. Does surgical relief of obstruction improve prognosis for hypertrophic cardiomyopathy? Ross RE; Sherrid MV; Casey MM; Swistel DG; Balaram SK Prog Cardiovasc Dis; 2012; 54(6):529-34. PubMed ID: 22687596 [TBL] [Abstract][Full Text] [Related]
10. Surgical myectomy versus alcohol septal ablation for obstructive hypertrophic cardiomyopathy. Will there ever be a randomized trial? Olivotto I; Ommen SR; Maron MS; Cecchi F; Maron BJ J Am Coll Cardiol; 2007 Aug; 50(9):831-4. PubMed ID: 17719467 [TBL] [Abstract][Full Text] [Related]
11. Long-term prognosis of hypertrophic cardiomyopathy after surgery. Balaram SK; Swistel DG Anadolu Kardiyol Derg; 2006 Dec; 6 Suppl 2():37-9. PubMed ID: 17162268 [TBL] [Abstract][Full Text] [Related]
12. Mechanisms for recurrent left ventricular outflow tract obstruction after septal myectomy for obstructive hypertrophic cardiomyopathy. Minakata K; Dearani JA; Schaff HV; O'Leary PW; Ommen SR; Danielson GK Ann Thorac Surg; 2005 Sep; 80(3):851-6. PubMed ID: 16122442 [TBL] [Abstract][Full Text] [Related]
13. [Therapy and risk-stratification in hypertrophic cardiomyopathy--a current survey]. Reith S; Klues HG Z Kardiol; 2003 Apr; 92(4):283-93. PubMed ID: 12707787 [TBL] [Abstract][Full Text] [Related]
14. Surgical septal myectomy versus alcohol septal ablation: assessing the status of the controversy in 2014. Maron BJ; Nishimura RA Circulation; 2014 Oct; 130(18):1617-24. PubMed ID: 25462821 [No Abstract] [Full Text] [Related]
15. A case series of myectomy: a review of its current application as an adjunct procedure. Niranjan G; Karagounis A; Asimakopoulos G; Wahed S; Chandrasekaran V J Card Surg; 2008; 23(4):391-3. PubMed ID: 18384569 [TBL] [Abstract][Full Text] [Related]
16. Residual and recurrent gradients after septal myectomy for hypertrophic cardiomyopathy-mechanisms of obstruction and outcomes of reoperation. Cho YH; Quintana E; Schaff HV; Nishimura RA; Dearani JA; Abel MD; Ommen S J Thorac Cardiovasc Surg; 2014 Sep; 148(3):909-15; discussion 915-6. PubMed ID: 24930617 [TBL] [Abstract][Full Text] [Related]
17. Expanding the indications for septal myectomy in patients with hypertrophic cardiomyopathy: results of operation in patients with latent obstruction. Schaff HV; Dearani JA; Ommen SR; Sorajja P; Nishimura RA J Thorac Cardiovasc Surg; 2012 Feb; 143(2):303-9. PubMed ID: 22154797 [TBL] [Abstract][Full Text] [Related]
18. Surgical management of obstructive hypertrophic cardiomyopathy: the gold standard. Brown ML; Schaff HV Expert Rev Cardiovasc Ther; 2008 Jun; 6(5):715-22. PubMed ID: 18510487 [TBL] [Abstract][Full Text] [Related]
19. Alcohol septal ablation versus surgical septal myectomy: comparison of effects on atrioventricular conduction tissue. Talreja DR; Nishimura RA; Edwards WD; Valeti US; Ommen SR; Tajik AJ; Dearani JA; Schaff HV; Holmes DR J Am Coll Cardiol; 2004 Dec; 44(12):2329-32. PubMed ID: 15607394 [TBL] [Abstract][Full Text] [Related]
20. Myectomy for hypertrophic obstructive cardiomyopathy. McRae ME Can J Cardiovasc Nurs; 2007; 17(2):22-30. PubMed ID: 17583317 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]